Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // November 4th, 2008 // 7:35 am
A big day here, of course, in the US, where elections are under way. And what could be more interesting than the race for the White House? Whatever your inclinations, do remember to vote. Meanwhile, here are a few items to digest while you mull over your fateful decision…
Gilead HIV Drug Gets Boost From US (TheStreet.com)
Investors Says Amylin Is Undervalued, Seeks Sale (Bloomberg News)
Judge Denies Another Breast Cancer-HRT Claim (The Legal Intelligencer)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Almylin Pharmaceuticals, Breast Cancer, Connecticut, Gilead Science, HRT, Job Cuts, Pfizer, Wyeth